AKR1B10 overexpression elevated the levels of phosphorylated-PI3K and phosphorylated-AKT, and not surprisingly, inhibition of AKR1B10 decreased the levels of these molecules in breast cancer cells (Fig. 4B, C). Here, AKR1B10 is linked to breast carcinoma.